Similar articles

• ICI 204,636: a new atypical antipsychotic drug.

  Hirsch SR, Link CG, Goldstein JM, Arvanitis LA. Hirsch SR, et al. Br J Psychiatry Suppl. 1996 May;(29):45-56. Br J Psychiatry Suppl. 1996. PMID: 8733823 Clinical Trial. No abstract available.
• Clinical findings. Abnormalities of the mental state and movement disorder and their correlates.

  Johnstone EC, Owens DG, Frith CD, Leary J. Johnstone EC, et al. Br J Psychiatry Suppl. 1991 Oct;(13):21-5, 44-6. Br J Psychiatry Suppl. 1991. PMID: 1688117 No abstract available.
• Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.

  Barnes TR, Liddle PF, Curson DA, Patel M. Barnes TR, et al. Br J Psychiatry Suppl. 1989 Nov;(7):99-103. Br J Psychiatry Suppl. 1989. PMID: 2575915 No abstract available.
• [Schizophrenic deficit syndrome and neurologic tolerance].

  Verdoux H, Bourgeois M. Verdoux H, et al. Encephale. 1996 Jun;22 Spec No 2:45-7. Encephale. 1996. PMID: 8767042 Review. French.
• New antipsychotic medications: do research results relate to clinical practice?

  MacEwan GW. MacEwan GW. Can J Psychiatry. 1993 Sep;38 Suppl 3:S75-9. Can J Psychiatry. 1993. PMID: 7504572 Review.